Skip to content

The research of the physique characteristics of Subclinical hypothyroidism and clinical intervention on Qi-depression type

The research of the physique characteristics of Subclinical hypothyroidism and clinical intervention on Qi-depression type

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006305
Enrollment
Unknown
Registered
2015-04-27
Start date
2015-05-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subclinical hypothyroidism

Interventions

the experimental group:Banxia Houpu decoction or granule
the control group:Placebo granule

Sponsors

Guang‘anmen Hospital, China Academy of Chinese Mdeical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Consistent with subclinical hypothyroidism and Western medicine diagnostic criteria; 2. between the ages of 18-80 years old (although the age >80 years old, but conscious, the successful completion of the respondents, but also included). The men and women is not restricted, open race; 3. with primary school or above (including primary school) education, can read the newspaper article; 4. free to accept the researchers asked, answer true; 5. agreed to use the data in the study group under the premise to protect their privacy.

Exclusion criteria

Exclusion criteria: 1. who did not meet the inclusion criteria; 2. the mentally ill, for respondents; 3. due to the language barrier to understanding and cooperation from other causes such as complete responders; 4. thyroid cancer, subacute thyroiditis, thyroid, treated by 131I; 5. and more serious underlying diseases, affect the questionnaire results accuracy, such as the merger of the following diseases: acute cerebral infarction, cerebral infarction, severe sequelae of severe kidney disease, severe lung disease, surgical diseases.

Design outcomes

Primary

MeasureTime frame
Thyroid function;Thyroid antibody;Thyroid ultrasonography;

Secondary

MeasureTime frame
TC, TG, HDL, LDL;

Countries

China

Contacts

Public ContactWei Junping
weijunping@126.com+86 13661067768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026